source
- UK science minister urges life-science firms to boost domestic investment as government raises medicine spendingAt a Financial Times Global Pharma and Biotech Summit, the UK science minister highlighted the need for greater domestic investment in life-science companies. The call follows a recent increase in…
- Hims & Hers pivots to branded GLP-1 drugs after striking deal with Eli LillyHims & Hers, which previously emphasized personalized care through compounded products, is changing its business model. The company is now focusing on established brand-name GLP-1 treatments rathe…